In Vitro Differentiated Adult Human Liver Progenitor Cells Display Mature Hepatic Metabolic Functions: A Potential Tool for in Vitro Pharmacotoxicological Testing

Abstract

The potential use of stem/progenitor cells as alternative cell sources to mature hepatocytes remains basically dependent on their ability to exhibit some, if not all, the metabolic liver functions. In the current study, four major liver functions were investigated in adult derived human liver stem/progenitor cell (ADHLSCs) populations submitted to in vitro hepatogenic differentiation: gluconeogenesis, ammonia detoxification, and activity of phase I and phase II drug-metabolizing enzymes. These acquired hepatic activities were compared to those of primary adult human hepatocytes, the standard reference. Amino acid content was also investigated after hepatogenic differentiation. Differentiated ADHLSCs display higher de novo synthesis of glucose correlated to an increased activity of glucose-6 phosphatase and mRNA expression of key related enzymes. Differentiated ADHLSCs are also able to metabolize ammonium chloride and to produce urea. This was correlated to an increase in the mRNA expression of relevant key enzymes such arginase. With respect to drug metabolism, differentiated ADHLSCs express mRNAs of all the major cytochromes investigated, among which the CYP3A4 isoform (the most important drug-metabolizing enzyme). Such increased expression is correlated to an enhanced phase I activity as independently demonstrated using fluorescence-based assays. Phase II enzyme activity and amino acid levels also show a significant enhancement in differentiated ADHLSCs. The current study, according to data independently obtained in different labs, demonstrates that in vitro differentiated ADHLSCs are able to display advanced liver metabolic functions supporting the possibility to develop them as potential alternatives to primary hepatocytes for in vitro settings.

β-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cells

“…As with many other epithelial cells [Khuu et al 2011;Russ et al 2008], PDCs rapidly lose their phenotype after enzymatic disruption of intracellular junctions and plating in adherent culture [Bonner-Weir et al 2000;Todorov et al 2006]. The loss of E-cadherin precedes mesenchymal marker expression, including N-cadherin and Snail1, the master regulator of epithelial-mesenchymal transition (EMT) [Lamouille et al 2014].…”

Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase

“…The PAH activity is also indicative of hepatocytes differentiation, as shown for other Brought to you by | Hemeroteca de Estudios Económicos -Banco de la República Authenticated Download Date | 11/13/14 6:00 PM metabolic enzymatic activities such as glucose-6-phosphatase, CYP450, urea production or albumin synthesis (20,21).…”

Treating inborn errors of liver metabolism with stem cells: current clinical development

“…Such potencies have been confirmed for adult-derived human liver stem cells (ADHLSCs) (Najimi et al 2007; Khuu et al 2011). Preclinical tests have also shown their in vivo differentiation after transplantation in mice (Najimi et al 2007; Khuu et al 2013).…”